Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

70°
- Benton, AR (72018)
  Today
  
  Showers likely and possibly a thunderstorm during the morning, then some lingering showers still possible this afternoon. High 77F. Winds light and variable. Chance of rain 70%..
  
  Tonight
  
  Partly cloudy skies this evening will become overcast overnight. Low near 65F. Winds light and variable.
  
  Updated: May 22, 2026 @ 11:33 am
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2026
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

813.48 -2.75 (-0.34%)

Streaming Delayed Price Updated: 12:34 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

This Emerging Market Could Be the Next Big Thing in Biotech ↗

July 14, 2023

Medicines to treat the many symptoms of long COVID are in high demand already.

Via The Motley Fool

Week In Review: Billion Dollar Deals - Moderna’s Shanghai Investment And F-Star’s Takeda Collaboration ↗

July 08, 2023

F-star Therapeutics formed a license agreement with Takeda to develop Fcab domains aimed at undisclosed immuno-oncology targets. Also, Brii Bio signed a global license to an HBV immunotherapeutic...

Via Talk Markets

argenx and Zai Lab Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China

June 30, 2023

From argenx SE

Via GlobeNewswire

Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China

June 30, 2023

From Zai Lab Limited

Via GlobeNewswire

The Latest Analyst Ratings for argenx ↗

June 07, 2023

Via Benzinga

Analyst Expectations for argenx's Future ↗

June 07, 2023

Via Benzinga

Expert Ratings for argenx ↗

May 31, 2023

Via Benzinga

Analyst Ratings for argenx ↗

April 21, 2023

Via Benzinga

A Bearish Sign Appears On argenx's Chart ↗

March 23, 2023

Via Benzinga

FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults ↗

June 27, 2023

The FDA approved UCB SA's (OTC: UCBJF) (OTC: UCBJY) Rystiggo (rozanolixizumab-noli) for generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AchR) or...

Via Benzinga

AstraZeneca Seeks Expanded Use For Soliris As First Targeted Therapy For Pediatric Patients With Autoimmune Neuromuscular Disease ↗

June 26, 2023

The European Union has reco

Via Benzinga

Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis ↗

June 21, 2023

The FDA has approved Argenx SE's (NASDAQ: ARGX) Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc), an injection for subcutaneous (SC) use for generalized myasthenia gravis (gMG) in adult...

Via Benzinga

argenx Announces U.S. Food and Drug Administration Approval of VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Generalized Myasthenia Gravis

June 20, 2023

From argenx SE

Via GlobeNewswire

Analyst Ratings for argenx ↗

March 20, 2023

Via Benzinga

Analyst Boosts Immunovant Price Target After Updated Pipeline Realignment ↗

March 20, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 20, 2023

Via Benzinga

argenx Initiates Second Cohort of Phase 2 ARDA Study of Empasiprubart in Multifocal Motor Neuropathy

June 20, 2023

From argenx SE

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023 ↗

May 31, 2023

Via Benzinga

argenx to Present at Upcoming Investor Conferences

May 31, 2023

From argenx SE

Via GlobeNewswire

Booking Holdings To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Friday ↗

May 05, 2023

Wells Fargo raised the price target for Royal Caribbean Cruises Ltd. (NYSE: RCL) from $78 to $88. Wells Fargo analyst Daniel Politzer maintained an Overweight rating. Royal Caribbean Cruises shares...

Via Benzinga

argenx Reports First Quarter 2023 Financial Results and Provides Business Update

May 04, 2023

From argenx SE

Via GlobeNewswire

argenx announces results of Annual General Meeting of Shareholders

May 03, 2023

From argenx SE

Via GlobeNewswire

argenx to Present at BofA Securities 2023 Health Care Conference

May 02, 2023

From argenx SE

Via GlobeNewswire

argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023

April 27, 2023

From argenx SE

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023 ↗

April 25, 2023

Via Benzinga

7 Biotech Stocks That Could Cure Your Portfolio Woes ↗

April 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

Via InvestorPlace

argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting

April 18, 2023

From argenx SE

Via GlobeNewswire

argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology

April 17, 2023

From argenx SE

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 12, 2023

Via Benzinga

argenx Announces Annual General Meeting of Shareholders on May 2, 2023

March 17, 2023

From argenx SE

Via GlobeNewswire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

argenx SE - American Depositary Shares (NQ:ARGX)

All News about argenx SE - American Depositary Shares

Sections

Services

Follow Us